Covington Capital Management’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $621K | Sell |
8,171
-50
| -0.6% | -$4.14K | 0.03% | 263 |
|
|
2022
Q2 | $695K | Buy |
8,221
+150
| +2% | +$13.2K | 0.03% | 257 |
|
|
2022
Q1 | $708K | Hold |
8,071
| – | – | 0.03% | 267 |
|
|
2021
Q4 | $706K | Sell |
8,071
-142
| -2% | -$11.8K | 0.02% | 249 |
|
|
2021
Q3 | $672K | Sell |
8,213
-25
| -0.3% | -$2.25K | 0.03% | 254 |
|
|
2021
Q2 | $752K | Buy |
8,238
+75
| +0.9% | +$6.68K | 0.03% | 245 |
|
|
2021
Q1 | $698K | Hold |
8,163
| – | – | 0.03% | 242 |
|
|
2020
Q4 | $771K | Sell |
8,163
-2,460
| -23% | -$215K | 0.03% | 227 |
|
|
2020
Q3 | $924K | Hold |
10,623
| – | – | 0.05% | 207 |
|
|
2020
Q2 | $928K | Buy |
10,623
+1,850
| +21% | +$160K | 0.05% | 204 |
|
|
2020
Q1 | $723K | Sell |
8,773
-230
| -3% | -$20.5K | 0.05% | 196 |
|
|
2019
Q4 | $852K | Buy |
9,003
+82
| +0.9% | +$7.36K | 0.04% | 207 |
|
|
2019
Q3 | $775K | Sell |
8,921
-800
| -8% | -$71.8K | 0.04% | 200 |
|
|
2019
Q2 | $888K | Sell |
9,721
-4,364
| -31% | -$369K | 0.05% | 188 |
|
|
2019
Q1 | $1.21M | Sell |
14,085
-671
| -5% | -$53.9K | 0.08% | 170 |
|
|
2018
Q4 | $1.14M | Buy |
14,756
+1,213
| +9% | +$94.4K | 0.08% | 165 |
|
|
2018
Q3 | $1.05M | Sell |
13,543
-28
| -0.2% | -$2.07K | 0.06% | 176 |
|
|
2018
Q2 | $919K | Sell |
13,571
-585
| -4% | -$40.4K | 0.06% | 185 |
|
|
2018
Q1 | $1.03M | Buy |
14,156
+856
| +6% | +$65.2K | 0.07% | 179 |
|
|
2017
Q4 | $1M | Sell |
13,300
-341
| -2% | -$25.7K | 0.06% | 182 |
|
|
2017
Q3 | $1.05M | Sell |
13,641
-1,395
| -9% | -$105K | 0.07% | 175 |
|
|
2017
Q2 | $1.13M | Sell |
15,036
-139
| -0.9% | -$9.85K | 0.09% | 148 |
|
|
2017
Q1 | $1.01M | Sell |
15,175
-13,510
| -47% | -$900K | 0.09% | 150 |
|
|
2016
Q4 | $1.87M | Sell |
28,685
-331
| -1% | -$21.5K | 0.17% | 125 |
|
|
2016
Q3 | $2.05M | Sell |
29,016
-3,636
| -11% | -$265K | 0.19% | 116 |
|
|
2016
Q2 | $2.41M | Sell |
32,652
-2,000
| -6% | -$138K | 0.22% | 112 |
|
|
2016
Q1 | $2.25M | Sell |
34,652
-14,878
| -30% | -$1.01M | 0.22% | 112 |
|
|
2015
Q4 | $3.82M | Buy |
49,530
+1,248
| +3% | +$99.1K | 0.37% | 85 |
|
|
2015
Q3 | $3.98M | Sell |
48,282
-2,464
| -5% | -$219K | 0.41% | 83 |
|
|
2015
Q2 | $4.47M | Buy |
50,746
+586
| +1% | +$53.8K | 0.4% | 82 |
|
|
2015
Q1 | $4.43M | Buy |
50,160
+2,391
| +5% | +$212K | 0.43% | 77 |
|
|
2014
Q4 | $3.97M | Buy |
47,769
+2,175
| +5% | +$180K | 0.35% | 91 |
|
|
2014
Q3 | $3.85M | Buy |
45,594
+4,719
| +12% | +$382K | 0.35% | 91 |
|
|
2014
Q2 | $3.35M | Buy |
40,875
+8,822
| +28% | +$694K | 0.3% | 98 |
|
|
2014
Q1 | $2.44M | Buy |
32,053
+6,185
| +24% | +$451K | 0.24% | 106 |
|
|
2013
Q4 | $1.86M | Buy |
25,868
+123
| +0.5% | +$8.55K | 0.19% | 117 |
|
|
2013
Q3 | $1.77M | Hold |
25,745
| – | – | 0.2% | 112 |
|
|
2013
Q2 | $1.63M | Buy |
+25,745
| New | +$1.68M | 0.2% | 111 |
|
Other funds holding NVS
Covington Capital Management's NVS Position: Q3 2022 in Review
Covington Capital Management reduced its Novartis (NVS) stake by 0.61% in Q3 2022, selling an estimated $4.14K and leaving 8,171 shares worth $621K. The position accounts for 0.03% of the portfolio, ranked #263.
Covington Capital Management first reported a position in NVS in Q2 2013 and has held it in 38 quarters since. The position peaked at $4.47M in Q2 2015. 1,089 funds tracked by Wall St. Rank hold NVS as of Q3 2022.
- Covington Capital Management held 8,171 shares of Novartis worth $621K as of Q3 2022.
- Covington Capital Management sold 50 Novartis shares in Q3 2022, an estimated $4.14K.
- Novartis made up 0.03% of Covington Capital Management's portfolio in Q3 2022, its #263 holding.
- Covington Capital Management first reported a position in Novartis in Q2 2013 and has held it in 38 quarters since.
- Covington Capital Management's Novartis position peaked at $4.47M in Q2 2015.
- 1,089 funds tracked by Wall St. Rank held Novartis as of Q3 2022.
Based on Covington Capital Management's 13F filing for Q3 2022, filed 15 Nov 2022.